30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High-throughput sequencing (HTS) of immunoglobulin (B-cell receptor, antibody) and T-cell receptor repertoires has increased dramatically since the technique was introduced in 2009 ( 13). This experimental approach explores the maturation of the adaptive immune system and its response to antigens, pathogens, and disease conditions in exquisite detail. It holds significant promise for diagnostic and therapy-guiding applications. New technology often spreads rapidly, sometimes more rapidly than the understanding of how to make the products of that technology reliable, reproducible, or usable by others. As complex technologies have developed, scientific communities have come together to adopt common standards, protocols, and policies for generating and sharing data sets, such as the MIAME protocols developed for microarray experiments. The Adaptive Immune Receptor Repertoire (AIRR) Community formed in 2015 to address similar issues for HTS data of immune repertoires. The purpose of this perspective is to provide an overview of the AIRR Community’s founding principles and present the progress that the AIRR Community has made in developing standards of practice and data sharing protocols. Finally, and most important, we invite all interested parties to join this effort to facilitate sharing and use of these powerful data sets ( join@ 123456airr-community.org ).

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          The promise and challenge of high-throughput sequencing of the antibody repertoire

          Georgiou and colleagues discuss rapidly evolving methods for high-throughput sequencing of the antibody repertoire, and how the resulting data may be applied to answer basic and translational research questions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS.

            IMGT/V-QUEST is the highly customized and integrated online IMGT(®) tool for the standardized analysis of the immunoglobulin (IG) or antibody and T cell receptor (TR) rearranged nucleotide sequences. The analysis of these antigen receptors represents a crucial challenge for the study of the adaptive immune response in normal and disease-related situations. The expressed IG and TR repertoires represent a potential of 10(12) IG and 10(12) TR per individual. This huge diversity results from mechanisms that occur at the DNA level during the IG and TR molecular synthesis. These mechanisms include the combinatorial rearrangements of the variable (V), diversity (D) and joining (J) genes, the N-diversity (deletion and addition at random of nucleotides during the V-(D)-J rearrangement) and, for IG, somatic hypermutations. IMGT/V-QUEST identifies the V, D, J genes and alleles by alignment with the germline IG and TR gene and allele sequences of the IMGT reference directory. The tool describes the V-REGION mutations and identifies the hot spot positions in the closest germline V gene. IMGT/V-QUEST integrates IMGT/JunctionAnalysis for a detailed analysis of the V-J and V-D-J junctions and IMGT/Automat for a complete annotation of the sequences and also provides IMGT Collier de Perles. IMGT/HighV-QUEST, the high-throughput version of IMGT/V-QUEST, implemented to answer the needs of deep sequencing data analysis from Next Generation Sequencing (NGS), allows the analysis of thousands of IG and TR sequences in a single run. IMGT/V-QUEST and IMGT/HighV-QUEST are available at the IMGT(®) Home page, http://www.imgt.org.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires.

              Driven by dramatic technological improvements, large-scale characterization of lymphocyte receptor repertoires via high-throughput sequencing is now feasible. Although promising, the high germline and somatic diversity, especially of B-cell immunoglobulin repertoires, presents challenges for analysis requiring the development of specialized computational pipelines. We developed the REpertoire Sequencing TOolkit (pRESTO) for processing reads from high-throughput lymphocyte receptor studies. pRESTO processes raw sequences to produce error-corrected, sorted and annotated sequence sets, along with a wealth of metrics at each step. The toolkit supports multiplexed primer pools, single- or paired-end reads and emerging technologies that use single-molecule identifiers. pRESTO has been tested on data generated from Roche and Illumina platforms. It has a built-in capacity to parallelize the work between available processors and is able to efficiently process millions of sequences generated by typical high-throughput projects.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/367669
                URI : http://frontiersin.org/people/u/42429
                URI : http://frontiersin.org/people/u/487574
                URI : http://frontiersin.org/people/u/442642
                URI : http://frontiersin.org/people/u/375370
                URI : http://frontiersin.org/people/u/348839
                URI : http://frontiersin.org/people/u/113039
                URI : http://frontiersin.org/people/u/476902
                URI : http://frontiersin.org/people/u/420095
                URI : http://frontiersin.org/people/u/486352
                URI : http://frontiersin.org/people/u/487578
                URI : http://frontiersin.org/people/u/167354
                URI : http://frontiersin.org/people/u/32061
                URI : http://frontiersin.org/people/u/88101
                URI : http://frontiersin.org/people/u/374384
                URI : http://frontiersin.org/people/u/88082
                URI : http://frontiersin.org/people/u/309225
                URI : http://frontiersin.org/people/u/487570
                URI : http://frontiersin.org/people/u/41770
                URI : http://frontiersin.org/people/u/88450
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                01 November 2017
                2017
                : 8
                : 1418
                Affiliations
                [1] 1Department of Biological Sciences, Simon Fraser University , Burnaby, BC, Canada
                [2] 2Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA, United States
                [3] 3La Jolla Institute for Allergy and Immunology , La Jolla, CA, United States
                [4] 4Department of Microbiology and Immunology, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine , Stanford, CA, United States
                [5] 5Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) , Bethesda, MD, United States
                [6] 6Division of B Cell Immunology, Deutsches Krebsforschungszentrum (DKFZ) , Heidelberg, Germany
                [7] 7Department of Neurology, Yale University School of Medicine , New Haven, CT, United States
                [8] 8Department of Clinical Sciences, University of Texas Southwestern Medical Center , Dallas, TX, United States
                [9] 9Department of Pathology, Yale University School of Medicine , New Haven, CT, United States
                [10] 10entre of Genomics and Policy, McGill University , Montreal, QC, Canada
                [11] 11Public Health Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center , Seattle, WA, United States
                [12] 12Department of Molecular Microbiology and Biotechnology, Tel Aviv University , Tel Aviv, Israel
                [13] 13Department of Genetics and Genome Sciences, Icahn School of Medicine at Mount Sinai , New York, NY, United States
                [14] 14Immunology-Immunopathology-Immunotherapy (i3 & i2B), Sorbonne Université , Paris, France
                [15] 15IMGT, LIGM, Institut de Génétique Humaine IGH, CNRS, University of Montpellier , Montpellier, France
                [16] 16School of Biotechnology and Biomolecular Sciences, University of New South Wales , Kensington, NSW, Australia
                [17] 17Faculty of Health Sciences, Simon Fraser University , Burnaby, BC, Canada
                [18] 18Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine , Louisville, KY, United States
                [19] 19Faculty of Health Sciences, Department of Molecular Biology and Biochemistry, Simon Fraser University , Burnaby, BC, Canada
                [20] 20Department of Microbiology, Boston University School of Medicine , Boston, MA, United States
                [21] 21Department of Mathematics and Statistics, Boston University , Boston, MA, United States
                Author notes

                Edited by: Gregory C. Ippolito, University of Texas at Austin, United States

                Reviewed by: Michael Zemlin, Universitätsklinikum des Saarlandes, Germany; Deborah K. Dunn-Walters, University of Surrey, United Kingdom

                *Correspondence: Felix Breden, breden@ 123456sfu.ca ; Eline T. Luning Prak, luning@ 123456pennmedicine.upenn.edu

                Specialty section: This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2017.01418
                5671925
                29163494
                73c49be9-61e2-4c76-aa77-26ec8417000a
                Copyright © 2017 Breden, Luning Prak, Peters, Rubelt, Schramm, Busse, Vander Heiden, Christley, Bukhari, Thorogood, Matsen IV, Wine, Laserson, Klatzmann, Douek, Lefranc, Collins, Bubela, Kleinstein, Watson, Cowell, Scott and Kepler.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 06 September 2017
                : 12 October 2017
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 69, Pages: 6, Words: 5428
                Funding
                Funded by: Canadian Institutes of Health Research 10.13039/501100000024
                Award ID: 137191
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: 1R13AI116349-01, P01-AI106697, P30-CA016520
                Funded by: Illumina 10.13039/100010905
                Funded by: Genentech 10.13039/100004328
                Funded by: Amgen 10.13039/100002429
                Categories
                Immunology
                Perspective

                Immunology
                b-cell receptors,t-cell receptors,data sharing,immunogenetics,community standards,high-throughput sequencing,immunoglobulins,antibodies

                Comments

                Comment on this article